相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors-A Review of Literature
Jan Korbecki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
BBB pathophysiology-independent delivery of siRNA in traumatic brain injury
Wen Li et al.
SCIENCE ADVANCES (2021)
Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma
Elena Tirro et al.
FRONTIERS IN ONCOLOGY (2021)
The Role of Selected Chemokines and Their Receptors in the Development of Gliomas
Magdalena Groblewska et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses
Joseph A. Westrich et al.
MOLECULAR CARCINOGENESIS (2020)
Hypoxia Alters the Expression of CC Chemokines and CC Chemokine Receptors in a Tumor-A Literature Review
Jan Korbecki et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
CXCL14 Maintains hESC Self-Renewal through Binding to IGF-1R and Activation of the IGF-1R Pathway
Chih-Lun Cheng et al.
CELLS (2020)
A Novel ACKR2-Dependent Role of Fibroblast-Derived CXCL14 in Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer
Elin Sjoberg et al.
CLINICAL CANCER RESEARCH (2019)
The Expression of the Chemokine CXCL14 Correlates with Several Aggressive Aspects of Glioblastoma and Promotes Key Properties of Glioblastoma Cells
Barbara Fazi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
HIC1 deletion promotes breast cancer progression by activating tumor cell/fibroblast crosstalk
Yingying Wang et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4
Paul J. Collins et al.
FASEB JOURNAL (2017)
A Crucial Role of CXCL14 for Promoting Regulatory T Cells Activation in Stroke
Hsu-Tung Lee et al.
THERANOSTICS (2017)
CXCL14 as an emerging immune and inflammatory modulator
Jing Lu et al.
JOURNAL OF INFLAMMATION-LONDON (2016)
The transcriptome and miRNome profiling of glioblastoma tissues and peritumoral regions highlights molecular pathways shared by tumors and surrounding areas and reveals differences between short-term and long-term survivors
Barbara Fazi et al.
ONCOTARGET (2015)
Livin Contributes to Tumor Hypoxia-Induced Resistance to Cytotoxic Therapies in Glioblastoma Multiforme
Chia-Hung Hsieh et al.
CLINICAL CANCER RESEARCH (2015)
Cancer-Associated Fibroblasts Expressing CXCL14 Rely upon NOS1-Derived Nitric Oxide Signaling for Their Tumor-Supporting Properties
Martin Augsten et al.
CANCER RESEARCH (2014)
CXCL14 is no direct modulator of CXCR4
Maik Otte et al.
FEBS LETTERS (2014)
CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis
Kosuke Tanegashima et al.
FEBS LETTERS (2013)
Pleiotropic functions of the CXC-type chemokine CXCL14 in mammals
Takahiko Hara et al.
JOURNAL OF BIOCHEMISTRY (2012)
Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1
Chii-Wen Chou et al.
NEURO-ONCOLOGY (2012)
NADPH Oxidase Subunit 4-Mediated Reactive Oxygen Species Contribute to Cycling Hypoxia-Promoted Tumor Progression in Glioblastoma Multiforme
Chia-Hung Hsieh et al.
PLOS ONE (2011)
CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth
Martin Augsten et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α
Shimin Zhao et al.
SCIENCE (2009)
IMC-A12, a human IgG, monoclonal antibody to the insulin-like growth factor I receptor
Eric K. Rowinsky et al.
CLINICAL CANCER RESEARCH (2007)
The hypoxic tumour microenvironment, patient selection and hypoxia-modifying treatments
I. J. Hoogsteen et al.
CLINICAL ONCOLOGY (2007)
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
J Soutschek et al.
NATURE (2004)
Tumor hypoxia:: Definitions and current clinical, biologic, and molecular aspects
M Höckel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
分享论文
